20 11, 2023 Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination Neal Evan Caminsky2023-11-20T15:09:51-05:00November 20, 2023|Funded Research Results, CoVaRR-Net Biobank|
6 11, 2023 Proof-of-vaccination policies in Canada led to higher vaccine uptake for the first few weeks after announcement in those under 50 years old Neal Evan Caminsky2023-11-03T14:00:54-04:00November 6, 2023|Funded Research Results, Pillar 8|
11 10, 2023 Use of whole genome sequencing to identify low-frequency mutations in SARS-COV-2 patients treated with remdesivir Neal Evan Caminsky2023-10-10T16:42:55-04:00October 11, 2023|Funded Research Results, Pillar 10|
27 09, 2023 Human-vision-inspired cluster identification for single-molecule localization microscopy Neal Evan Caminsky2023-09-27T14:09:54-04:00September 27, 2023|Funded Research Results, Pillar 1|
26 09, 2023 Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study Neal Evan Caminsky2023-09-26T10:49:59-04:00September 26, 2023|Funded Research Results, Pillar 4|
26 09, 2023 Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases Neal Evan Caminsky2023-09-26T10:41:44-04:00September 26, 2023|Funded Research Results, Pillar 4|
29 08, 2023 A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants Neal Evan Caminsky2023-08-29T11:51:33-04:00August 29, 2023|Funded Research Results, Pillar 10|
21 08, 2023 Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals Neal Evan Caminsky2023-08-23T14:40:13-04:00August 21, 2023|Funded Research Results, Pillar 2|
21 08, 2023 Clinical and serological predictors of Post COVID-19 Condition: Findings from a Canadian prospective cohort study Neal Evan Caminsky2023-08-23T14:41:36-04:00August 21, 2023|Funded Research Results, Pillar 9|
21 08, 2023 The metallodrug BOLD-100 is a potent inhibitor of SARS-CoV-2 replication and has broad-acting antiviral activity Neal Evan Caminsky2023-08-21T09:32:06-04:00August 21, 2023|Funded Research Results, Pillar 3|
